Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response

Status: open

17-149 - Phase 2 Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients w/ Clinical/Radiologic Complete Response After Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment without Surgery

Treatment for Breast Cancer

Contact Us Or call (251) 445-9834

Description

This phase II trial studies how well biopsy of breast after chemotherapy works in predicting pathologic response in patients with stage II-IIIA breast cancer undergoing breast conserving surgery. Tumor tissue collected from biopsy before surgery may help to check if chemotherapy destroyed the breast cancer cells and may be compared to the tumor removed during surgery to check if they are the same. IRB Number 17-149

Sponsors

This trial is sponsored by NRG.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

This link will open in a new tab or window.